Intuitive Surgical, Inc. ISRG

405.18 5.66 1.42% as of 25 Sep
Market cap
$140.7B
P/E
45.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Intuitive Surgical, Inc. (ISRG) EV/EBITDA

As of 25 September 2026, Intuitive Surgical, Inc. (ISRG) trades at a EV/EBITDA of 32.5×. Over the past ten years it has ranged from 18.6× (October 2015) to 74.8× (November 2024); the current reading is higher than 26% of that period. That is above the Medical Instruments & Supplies industry median of 16.1× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 54.2× (14.94%)
FY2024 63.7× 27.42%
FY2023 50.0× 8.91%
FY2022 45.9× (19.77%)
FY2021 57.2× (15.25%)
FY2020 67.5× 65.14%
FY2019 40.9× 5.98%
FY2018 38.6× 13.19%
FY2017 34.1× 62.68%
FY2016 20.9× (4.17%)

Quarterly

Period EV/EBITDA Change
Jun 2026 31.9× (20.70%)
Mar 2026 40.2× (25.78%)
Dec 2025 54.2× 20.36%
Sep 2025 45.0× (24.45%)
42 more quarters

Against its own ten years

Low 18.6× High 74.8×
Ten-year median 42.0×
Current reading's percentile 26

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 3.9×
SOLV Solventum Corporation compare 7.9×
ALC Alcon compare 12.7×
BDX Becton, Dickinson and Company compare 13.3×
BAX Baxter International Inc. compare 13.3×
RMD ResMed Inc. compare 14.7×
WST West Pharmaceutical Services, Inc. compare 30.2×
ISRG Intuitive Surgical, Inc. 32.5×
RGEN Repligen Corporation compare 65.3×
Medical Instruments & Supplies industry median 16.1×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ISRG